• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度至中度溃疡性结肠炎的实用管理:国际专家共识。

Practical management of mild-to-moderate ulcerative colitis: an international expert consensus.

机构信息

Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, Milan, Italy.

CINTESIS@RISE, Faculty of Medicine, The University of Porto, Porto, Portugal.

出版信息

Expert Rev Gastroenterol Hepatol. 2024 Aug;18(8):421-430. doi: 10.1080/17474124.2024.2397650. Epub 2024 Sep 3.

DOI:10.1080/17474124.2024.2397650
PMID:39225555
Abstract

INTRODUCTION

Although there are well-defined guidelines for the management of mild-to-moderate ulcerative colitis (UC), there are still unmet needs. For this reason, we conducted an international expert consensus to standardize the management of patients with mild-to-moderate UC and provide practical guidance to clinicians.

AREAS COVERED

Based on Delphi methodology, 15 statements were approved after two rounds of voting, addressing several aspects of disease management from sequencing to treatment duration, from monitoring to optimization techniques and safety profile.

EXPERT OPINION

Growing knowledge of mild-to-moderate UC has led to the development of new ambitious outcomes such as histological remission and disease clearance. Furthermore, noninvasive tools for patient monitoring such as fecal calprotectin and intestinal ultrasound are now available. Their implementation in clinical practice will allow clinicians to tightly monitor disease activity and promptly adapt treatment, avoiding complications and disease progression and targeting better disease control.

摘要

简介

尽管对于轻中度溃疡性结肠炎(UC)的管理有明确的指南,但仍存在未满足的需求。因此,我们进行了一项国际专家共识,以规范轻中度 UC 患者的管理,并为临床医生提供实用的指导。

涵盖领域

基于德尔菲法,经过两轮投票,批准了 15 项声明,这些声明涉及疾病管理的多个方面,从治疗顺序到治疗持续时间,从监测到优化技术和安全性。

专家意见

对轻中度 UC 的认识不断提高,导致出现了新的治疗目标,如组织学缓解和疾病清除。此外,现在还可以使用粪便钙卫蛋白和肠道超声等非侵入性工具来监测患者。在临床实践中应用这些工具可以让临床医生密切监测疾病活动,并及时调整治疗,避免并发症和疾病进展,实现更好的疾病控制。

相似文献

1
Practical management of mild-to-moderate ulcerative colitis: an international expert consensus.轻度至中度溃疡性结肠炎的实用管理:国际专家共识。
Expert Rev Gastroenterol Hepatol. 2024 Aug;18(8):421-430. doi: 10.1080/17474124.2024.2397650. Epub 2024 Sep 3.
2
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus.疾病缓解成为溃疡性结肠炎的新结局:系统评价和专家共识。
Inflamm Bowel Dis. 2024 Jun 3;30(6):1009-1017. doi: 10.1093/ibd/izad159.
3
Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus.轻度至中度溃疡性结肠炎患者的治疗:中东专家共识
J Clin Med. 2023 Nov 4;12(21):6929. doi: 10.3390/jcm12216929.
4
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.中重度炎症性肠病的常规治疗:系统文献回顾。
World J Gastroenterol. 2019 Mar 7;25(9):1142-1157. doi: 10.3748/wjg.v25.i9.1142.
5
Management and treatment optimization of patients with mild to moderate ulcerative colitis.轻度至中度溃疡性结肠炎患者的管理和治疗优化。
Expert Rev Clin Immunol. 2024 Mar;20(3):277-290. doi: 10.1080/1744666X.2023.2292768. Epub 2023 Dec 12.
6
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®) for active, mild-to-moderate ulcerative colitis.一项评估布地奈德 MMX(Cortiment)治疗活动期、轻中度溃疡性结肠炎有效性的多中心前瞻性队列研究。
United European Gastroenterol J. 2019 Nov;7(9):1171-1182. doi: 10.1177/2050640619864848. Epub 2019 Jul 17.
7
Algorithms to facilitate shared decision-making for the management of mild-to-moderate ulcerative colitis.用于轻度至中度溃疡性结肠炎管理的共享决策制定的算法。
Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1079-1100. doi: 10.1080/17474124.2018.1530109. Epub 2018 Oct 17.
8
Oral budesonide for induction of remission in ulcerative colitis.口服布地奈德诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007698. doi: 10.1002/14651858.CD007698.pub3.
9
E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.电子健康:溃疡性结肠炎的网络引导治疗与疾病自我管理。对疾病转归、生活质量及依从性的影响。
Dan Med J. 2012 Jul;59(7):B4478.
10
Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.粪便钙卫蛋白和临床活动指数均有助于监测溃疡性结肠炎患者的治疗。
Dig Dis Sci. 2015 Feb;60(2):485-91. doi: 10.1007/s10620-014-3383-0. Epub 2014 Oct 26.

引用本文的文献

1
Non-Adherence Rate to Oral Mesalamine in Ulcerative Colitis Patients: A Systematic Review with Meta-Analysis.溃疡性结肠炎患者口服美沙拉嗪的不依从率:一项系统评价与荟萃分析
J Pers Med. 2025 Mar 24;15(4):123. doi: 10.3390/jpm15040123.
2
[Efficient treatment of mild Crohn's disease and mild ulcerative colitis].[轻度克罗恩病和轻度溃疡性结肠炎的有效治疗]
Inn Med (Heidelb). 2025 Jan;66(1):15-21. doi: 10.1007/s00108-024-01840-x. Epub 2024 Dec 23.